Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

Related Keywords

San Diego ,California ,United States ,Mohammad Ahmadian ,Jay Hagan ,Company Collaboration ,Rnas The Company Or Regulus ,Regulus Therapeutics Inc ,Drug Administration ,Nasdaq ,Exchange Commission ,Development Rd Expenses ,Enterprise Associates ,Kinovate Life Sciences Inc ,Program Updates ,Alport Syndrome ,License Agreement ,Private Placement ,Federated Hermes Kaufmann Funds ,New Enterprise Associates ,Common Stock ,Vice President ,President Director ,Kinovate Life Sciences ,Webcast Information ,Private Securities Litigation Reform Act ,